Oramed Pharmaceuticals, Inc. (ORMP)
4.74
+0.07
(+1.50%)
USD |
NASDAQ |
Sep 18, 16:00
4.74
0.00 (0.00%)
After-Hours: 20:00
Oramed Pharmaceuticals Cash from Investing (Quarterly) : 3.920M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.920M |
| March 31, 2026 | -19.49M |
| December 31, 2025 | -1.679M |
| September 30, 2025 | 38.82M |
| June 30, 2025 | -54.98M |
| March 31, 2025 | 23.62M |
| December 31, 2024 | 15.69M |
| September 30, 2024 | -33.59M |
| June 30, 2024 | 93.63M |
| March 31, 2024 | 30.00M |
| December 31, 2023 | 29.31M |
| September 30, 2023 | -72.32M |
| June 30, 2023 | -14.26M |
| March 31, 2023 | -13.20M |
| December 31, 2022 | 10.71M |
| September 30, 2022 | 1.053M |
| June 30, 2022 | 9.963M |
| March 31, 2022 | 7.359M |
| August 31, 2021 | -27.91M |
| May 31, 2021 | 7.496M |
| February 28, 2021 | -3.358M |
| November 30, 2020 | 1.199M |
| August 31, 2020 | 10.95M |
| May 31, 2020 | -13.20M |
| February 29, 2020 | 4.127M |
| Date | Value |
|---|---|
| November 30, 2019 | 2.825M |
| August 31, 2019 | 2.759M |
| May 31, 2019 | 4.31M |
| February 28, 2019 | 1.429M |
| November 30, 2018 | 2.995M |
| August 31, 2018 | -10.55M |
| May 31, 2018 | 3.90M |
| February 28, 2018 | 4.795M |
| November 30, 2017 | -5.146M |
| August 31, 2017 | 3.014M |
| May 31, 2017 | 2.637M |
| February 28, 2017 | 2.087M |
| November 30, 2016 | -3.436M |
| August 31, 2016 | -6.31M |
| May 31, 2016 | 2.242M |
| February 29, 2016 | -12.76M |
| November 30, 2015 | 0.818M |
| August 31, 2015 | -4.485M |
| May 31, 2015 | 3.65M |
| February 28, 2015 | -3.953M |
| November 30, 2014 | 1.476M |
| August 31, 2014 | 0.0914M |
| May 31, 2014 | 0.1139M |
| February 28, 2014 | -13.13M |
| November 30, 2013 | -0.1622M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly & Co. | -15.40B |
| Pfizer Inc. | 2.106B |
| Liquidia Corp. | -12.24M |
| Scilex Holding Co. | 8.452M |
| BioAge Labs, Inc. | -164.51M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.2799M |
| Cash from Financing (Quarterly) | -2.265M |
| Free Cash Flow | -5.820M |
| Free Cash Flow Per Share (Quarterly) | -0.0066 |
| Free Cash Flow to Equity (Quarterly) | -0.2541M |
| Free Cash Flow to Firm (Quarterly) | -0.2821M |
| Free Cash Flow Yield | -2.93% |